IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients.
about
Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicineT follicular helper cells, interleukin-21 and systemic lupus erythematosus.Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review.
P2860
IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@en
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@nl
type
label
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@en
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@nl
prefLabel
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@en
IL2/IL21 region polymorphism i ...... lupus erythematosus patients.
@nl
P2093
P2860
P50
P1476
IL2/IL21 region polymorphism i ...... c lupus erythematosus patients
@en
P2093
Cristina Lucía Dávila-Fajardo
Enrique de Ramón Garrido
Gema Robledo
Javier Martín
José Cabeza Barrera
José Luis Callejas Rubio
Ma Francisca González-Escribano
Ma Jesús Castillo Palma
Ma Teresa Camps García
Ma del Mar Ayala
P2860
P2888
P304
P356
10.1007/S11033-013-2583-6
P577
2013-05-05T00:00:00Z